Immuno-oncology continues to evolve rapidly, with growing focus on the tumor microenvironment and next-generation immune checkpoints such as TIGIT and LAG-3, alongside PD-1 and CTLA-4.
These targets are opening new opportunities to better understand and overcome immune evasion in cancer.
At the same time, cytokine profiling remains essential for decoding immune responses. Moving from single-analyte assays to multiplex approaches allows researchers to gain a broader, more accurate picture of immune activity.
As the official representatives of Bio-Techne in Israel, we offer a wide range of solutions to support your research – from validated antibodies and recombinant cytokines to Quantikine™ ELISA kits, Luminex® multiplex panels, and Simple Plex™ automated assays. These tools enable reliable, sensitive, and scalable analysis across immunology and cancer applications.
For more information:
https://www.bio-techne.com/research-areas/cancer
We’re here to help you move from discovery to results – faster and with confidence